Proton Therapy in a Pandemic: An Operational Response to the COVID-19 Crisis

• Susan L. McGovern, MD, PhD,
• Cody Wages, CMD,
• Andrew Dimmitt, RTT,
• Christopher Sanders, RTT,
• Deanna Martin,
• Matthew S. Ning, MD,
• Rochelle Manning, MSN, RN,
• Mayank Amin, CMD,
• X. Ronald Zhu, PhD,
• Steven J. Frank, MD,
• G. Brandon Gunn, MD

Affiliations

Susan L. McGovern, MD, PhD

Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

Cody Wages, CMD

Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

Andrew Dimmitt, RTT

Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

Christopher Sanders, RTT

Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

Deanna Martin

Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

Matthew S. Ning, MD

Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

Rochelle Manning, MSN, RN

Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

Mayank Amin, CMD

Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

X. Ronald Zhu, PhD

Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

Steven J. Frank, MD

Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

G. Brandon Gunn, MD

Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA